Convatec maintains guidance, despite wound care decline

A pause on elective surgeries during lockdown dealt a blow to Convatec’s (CTEC) advanced wound care business. Indeed, first-half revenues here fell by 7.6 per cent to $251m (£191m) – or by 4.8 per cent at constant currencies.